Stay updated on Apremilast-Dupilumab Combo in Eczema Clinical Trial
Sign up to get notified when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.

Latest updates to the Apremilast-Dupilumab Combo in Eczema Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page footer now displays Revision: v3.6.3, indicating a minor platform update to the site. This update does not modify the study details or results.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a backend update rather than changes to the displayed study details.SummaryDifference0.1%

- Check31 days agoChange DetectedEnrollment status now shows 'No longer looking for participants' and several user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The 'Intervention/Treatment' heading was reformatted and a site revision note 'Revision: v3.6.0' was included.SummaryDifference0.5%

- Check38 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing v3.5.4, indicating a site version update. This change appears to be behind-the-scenes and does not alter study content or user-facing functionality.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.5.4 was added in the page footer, replacing the previous Revision: v3.5.3. This represents a small version update and does not modify study details or primary content on the page.SummaryDifference0.1%

- Check80 days agoChange DetectedUpdates the ClinicalTrials.gov page revision indicator from v3.5.2 to v3.5.3 without changing the study content shown in the record.SummaryDifference0.1%

Stay in the know with updates to Apremilast-Dupilumab Combo in Eczema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.